Respiratory Infections News

Throughout the COVID-19 pandemic, World TB Day, which is observed each year on March 23, has marked the need for more — more research, more testing, more treatment options, and more access for patients globally.

Cases of tuberculosis increased in the U.S. in 2022 but did not return to pre-pandemic levels, according to data published in a Morbidity and Mortality Weekly Report ahead of World TB Day.

The real-world use of Pneumocystis jirovecii pneumonia prophylaxis in patients with systemic lupus erythematous is “much lower” than prior survey-based studies suggest, according to data published in Seminars in Arthritis and Rheumatism.

Most patients with latent tuberculosis receiving a once-weekly combination of rifapentine and isoniazid reported symptoms that resolved without stopping treatment, researchers found, suggesting the treatment is convenient and effective.

The public health and national emergencies related to the COVID-19 pandemic are set to end on May 11.

The public health and national emergencies related to the COVID-19 pandemic are set to end on May 11.

Over the past several years, adult pneumococcal vaccine recommendations have evolved based on the development of new vaccines.

My journey in infectious diseases started out with an intense hatred and utter confusion.

Currently, the Bacillus Calmette-Guérin vaccine from 1921 is the only available vaccine for tuberculosis, according to a press release from the European Society of Clinical Microbiology and Infectious Diseases.

The FDA’s Antimicrobial Drugs Advisory Committee voted Thursday to support the approval of Paxlovid for the treatment of mild-to-moderate COVID-19 in adults at high risk for severe disease, hospitalization or death.